|
|||||
![]() |
|
Health and wellness products company USANA Health Sciences (NYSE:USNA) announced better-than-expected revenue in Q2 CY2025, with sales up 10.8% year on year to $235.8 million. The company’s full-year revenue guidance of $960 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $0.74 per share was 37% above analysts’ consensus estimates.
Is now the time to buy USNA? Find out in our full research report (it’s free).
USANA’s second quarter results were met with a positive market reaction, driven by revenue and non-GAAP earnings that both exceeded Wall Street expectations. Management attributed this performance to the implementation of strategic initiatives, including a shift in sales terminology and compensation structure, and increased momentum in its recently acquired businesses. CEO Jim Brown highlighted that the company’s direct-to-consumer platform Hiya achieved strong growth and improved profitability, while the refreshed approach to brand partners and expanded product offerings contributed to higher engagement and sales activity.
Looking forward, USANA’s outlook is shaped by ongoing enhancements to its direct sales model and plans for additional product launches. Management emphasized that the new compensation plan and business tools are designed to accelerate customer acquisition and retention, with further rollouts scheduled for the third quarter. CEO Jim Brown stated that these updates, along with upcoming product introductions at the company’s global convention, are expected to boost brand partner engagement and support sustainable long-term growth. Management also noted that investments tied to these initiatives may lead to near-term margin pressure.
Management pointed to several operational and strategic changes as key contributors to the quarter’s growth, with a focus on new sales infrastructure, compensation changes, and acquired business integration.
USANA’s management expects future growth to be driven by recent sales model changes, new product launches, and integration progress with acquired businesses, while keeping an eye on cost pressures and macroeconomic factors.
Looking ahead, the StockStory team will closely watch (1) the impact of the new compensation plan and business tools on customer acquisition and partner retention, (2) the success of product launches and incentive programs revealed at the global convention, and (3) operational progress in integrating Hiya and expanding its distribution. Execution in these areas will clarify whether USANA’s strategies can drive sustained growth and margin improvement.
USANA currently trades at $32.50, up from $31.53 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
Donald Trump’s April 2024 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
7 hours | |
7 hours | |
8 hours | |
Aug-12 | |
Aug-06 | |
Aug-05 | |
Aug-05 | |
Aug-04 | |
Jul-30 | |
Jul-29 | |
Jul-25 | |
Jul-24 | |
Jul-24 | |
Jul-24 | |
Jul-23 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite